HCV Dual Probe

Redefining HCV Viral Load Monitoring

The first FDA-approved HCV RNA viral load test for use as an aid in the diagnosis of active HCV infections.

HCV — An ever-changing virus

Accurately detect and quantitate all HCV genotypes 1 through 6

The combination of error-prone RNA replication with a high rate of virus production results in extreme genetic variability of hepatitis C virus (HCV). A quantitative HCV RNA test must thus be able to tolerate sequence mismatches for accurate and reliable results.

Two non-overlapping detection probes, when combined with two staggered primers, ensure assay performance with HCV isolates containing sequence heterogeneity.
Mismatch tolerance enables the test to accurately quantify the target despite nucleotide changes in the viral genome while maintaining high specificity for HCV RNA.

Roche Dual Probe HCV

Update Required To play the media you will need to either update your browser to a recent version or update your Flash plugin.

^{References:

1. cobas® HCV Package Insert 07175418001-01EN ver 1.0.}

Redefining HCV Viral Load Monitoring

Accurately detect and quantitate all HCV genotypes 1 through 6

Related assays